LAVA Therapeutics Statements
LV
Data from LAVA Therapeutics`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2024
Next reporting period:
29 Dec, 2024
Report frequency:
Quarterly
Earnings release date:
—
Expected release date:
25 Nov, 2024
LAVA Therapeutics Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
—
—
100
—
0
—
—
0
8.5
0
2.785
0
11.285
20.6 %
0
-11.285
-20.6 %
0
-0.915
0
—
0
-12.2
-48.6 %
0
0.096
0
-12.296
-48.2 %
0
-0.458
26.846
—
-100 %
100
—
0
—
-100 %
0
6.336
0
3.025
0
9.361
4.7 %
0
-9.361
-379.6 %
0
1.15
0
—
0
-8.211
-1596.5 %
0
0.085
0
-8.296
-1400.2 %
0
-0.309
26.822
6.992
1880.7 %
100
—
0
6.992
3413.6 %
100
6.009
85.9
2.935
42
8.944
58.6 %
127.9
-1.952
64.1 %
-27.9
1.468
21
—
0
-0.484
92.5 %
-6.9
0.069
1
-0.553
91.5 %
-7.9
-0.021
26.794
0.353
566 %
100
0.154
43.6
0.199
362.8 %
56.4
3.36
951.8
2.281
646.2
5.641
-47.6 %
1598
-5.442
49.3 %
-1541.6
-0.995
-281.9
—
0
-6.437
26.7 %
-1823.5
0.061
17.3
-6.498
26.5 %
-1840.8
-0.232
28.063
0.053
-99 %
100
0.01
18.9
0.043
-98.4 %
81.1
7.912
14928.3
2.858
5392.5
10.77
-33.9 %
20320.8
-10.727
20.8 %
-20239.6
1.941
3662.3
—
0
-8.786
30.3 %
-16577.4
0.05
94.3
-8.836
30.4 %
-16671.7
-0.336
26.289
5.14
321.3 %
100
2.39
46.5
2.75
848.3 %
53.5
12.6
245.1
3.7
72
16.29
17.8 %
316.9
-13.55
-0.1 %
-263.6
0.94
18.3
—
0
-12.6
9.2 %
-245.1
0.1
1.9
-12.7
8.9 %
-247.08
-0.48
26.29
1.22
-53.8 %
100
0.93
76.2
0.29
—
23.8
9.94
814.8
3.89
318.9
13.83
-2.6 %
1133.6
-13.54
-17.1 %
-1109.8
-0.33
-27.05
—
0
-13.87
7.1 %
-1136.9
0.07
5.7
-13.94
7.1 %
-1142.6
-0.53
26.29
2.64
-82.7 %
100
—
0
—
—
0
10.49
397.3
3.71
140.5
14.2
-15.3 %
537.9
-11.56
-665.6 %
-437.9
-3.37
-127.7
—
0
-14.93
-1535.6 %
-565.5
0.07
2.7
-15
-1600 %
-568.2
-0.57
26.29
15.26
3146.8 %
100
—
0
—
—
0
13.68
89.6
3.1
20.3
16.77
45.3 %
109.9
-1.51
86.4 %
-9.9
2.55
16.7
—
0
1.04
113 %
6.8
0.05
0.3
1
112.3 %
6.6
0.04
26.45
0.47
-53.9 %
100
—
0
—
—
0
8.37
1780.9
3.17
674.5
11.54
-1.6 %
2455.3
-11.08
-3.5 %
-2357.4
3.05
648.9
—
0
-8.03
17.7 %
-1708.5
0.08
17
-8.11
17.4 %
-1725.5
-0.31
25.78
1.02
-70.9 %
100
—
0
—
—
0
7.5
735.3
4.24
415.7
11.73
-36.3 %
1150
-10.71
28.2 %
-1050
0.95
93.1
—
0
-9.76
36.9 %
-956.9
0.06
5.9
-9.82
36.7 %
-962.7
-0.38
25.78
3.5
438.5 %
100
—
0
—
—
0
15.7
448.6
2.72
77.7
18.42
127.1 %
526.3
-14.92
-100 %
-426.3
-0.54
-15.4
—
0
-15.46
-96.4 %
-441.7
0.04
1.1
-15.51
-97.1 %
-443.1
-0.61
25.35
0.65
—
100
—
0
—
—
0
6.62
1018.5
1.49
229.2
8.11
—
1247.7
-7.46
—
-1147.7
-0.41
-63.08
—
0
-7.87
—
-1210.8
—
0
-7.87
—
-1210.8
-0.31
25.35